得久力膜衣錠30毫克

Negara: Taiwan

Bahasa: China

Sumber: 衛生福利部食品藥物管理署 (Ministry of Health and Welfare, Food And Drug Administration)

Bahan aktif:

DAPOXETINE HYDROCHLORIDE

Tersedia dari:

培力藥品工業股份有限公司 台中市西屯區工業區六路１１號 (52260152)

Kode ATC:

G04BX14

Bentuk farmasi:

膜衣錠

Komposisi:

DAPOXETINE HYDROCHLORIDE (2816402510) MG

Unit dalam paket:

AL-AL鋁箔盒裝

Kelas:

製　劑

Jenis Resep:

須由醫師處方使用

Diproduksi oleh:

培力藥品工業股份有限公司 台中市西屯區工業區六路１１號 TW

Area terapi:

dapoxetine

Indikasi Terapi:

用於治療年齡18-64歲且符合下列所有條件的早發性射精男性：1.陰道內射精潛伏時間短於2分鐘。2.難以控制射精，在性行為插入之前、當時或不久後經過輕微刺激，發生持續或復發性射精。3.因為早發性射精而導致病人明顯沮喪。

Ringkasan produk:

有效日期: 2025/10/21; 英文品名: Dabuxin F.C. Tablets 30mg

Tanggal Otorisasi:

2020-10-21

Selebaran informasi

DPTD-1_01
060567
Dapoxetine
3030Dapoxetine
Lactose, Microcrystalline Cellulose, Croscarmellose Sodium, Colloid
Silicon Dioxide, Magnesium Stearate,
Opadry OY-7300 White
30mgPL”T67”
Dapoxetine18-64
1. (IELT)
2.
3.
(light
headedness)
a. (18-64
)
Dapoxetine
3013
Dapoxetine
Dapoxetine
b. 65
65
c.
Dapoxetine18
d.
Dapoxetine
e.
Child-PughB
C Dapoxetine
f. CYP2D6
CYP2D6
CYP2D6CYP2D6
Dapoxetine
CYP2D6CYP3A4
g. CYP3A4
DapoxetineCYP3A4CYP3A4Dapoxetine30
1.DapoxetineCYP2D6Fluoxetine
duloxetine
bupropion
terbenafine
CYP3A4
2.DapoxetineDapoxetine
3.Dapoxetine
a.NYHA
b.
c.
d.
4.Dapoxetinemonoamine oxidase inhibitors, MAOIsMAOIs
14
Dapoxetine
MAOI
5.Dapoxetine
thioridazinethioridazine
14
DAPOXETINEthioridazine
6.Dapoxetineselective serotonin reuptake inhibitors,
SSRIs)
-serotonin-norepinephrine reuptake inhibitors, SNRIs
tricyclic antidepressants, TCAsL-tryptophan
triptanstramadol
linezolid
St. John’s Wort, Hypericum perforatum
14Dapoxetine
7.DapoxetineCYP3A4ketoconazole
itraconazole
ritonavir
saquinavir
telithromyci
n
nefazadone
nelfinavir
atazanavir
8.Dapoxetine
Dapoxetine
Dapoxetine
D a p o x e t i n e
k e t a m i n e
methylenedioxymethamphetamine
(MDMA) lysergic acid diethylamide (LSD)Dapoxetine
Dapoxetinebenzodiazepines
Dapoxetinealcohol−related neurocognitive effectsneurocardiogenic
Dapoxetine
30
0.19%
223
15
4
1
28
0.06%30mg0.23%60mg
0.64%
Dapoxetine
Prodromal symptoms
(light headedness)
30Dapoxetine:
(11.0%)(5.8%)/
(0.8%)
60Dapoxetine(21.2%)(11.7%)/
(1.5%)
(dose-dependent)
Prodromal
symptoms (light headedness)
Dapoxetine
Dapoxetineneurocardiogenic:
Dapoxetine
outflow obstruction
Dapoxetine
Dapoxetine
α
PDE5
CYP3A4
DapoxetineCYP3A430
CYP2D6
Dapoxetine
CYP2D6
CYP3A4
SSRIs
24DAPOXETINE
DapoxetineDapoxetine
SSRIsDapoxetine
DapoxetineDABUXIN
Dapoxetine
Dapoxetine
DapoxetineSSRIs SNRIs
Dapoxetine
Dapoxetine
Dapoxetine
SSRIsDapoxetine
phenothiazines
acetylsalicylic acidNSAIDs
warfarin
Dapoxetine
SSRIs
6260mg
Dapoxetine
(galactose intolerance)
Lapp
(Lapp lactase deficiency)
-
α-
PDE5
1.
a. monoamine oxidase inhibitor